Amelioration of lipid profile and level of antioxidant activities by epigallocatechin-gallate in a rat model of atherogenesis

Heart Lung and Circulation

Volumn 23, Issue 12, 2014, Pages 1194-1201

  Xu, Xuelian ^a   Pan, Jianxing ^a   Zhou, Xiaoli ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidants; Atherogenic diet; Atherosclerosis; Epigallocatechin gallate; Oxidative stress

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CATALASE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; ANTIOXIDANT; CATECHIN; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; LIPID PEROXIDATION; MALE; MORPHOMETRICS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RISK ASSESSMENT; RISK FACTOR; TISSUE HOMOGENATE; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CATECHIN; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; LIPIDS; MALE; RATS; RATS, WISTAR;

EID: 84912568351     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.05.013     Document Type: Article

References (45)

1. Chan K., Lu R., Chang J.C., Kan Y.W. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A. 1996, 93:13943-13948. 1996.
2. Araujo J.A., Barajas B., Kleinman M., Wang X.P., Bennett B.J., Gong K.W., et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 2008, 102:589-596.
3. Balkan J., Kanbagli O., Hatipoglu A., Kuquk M., Qevikbas U., Aykaq-Toker G., et al. Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet. Biosci Biotechnol Biochem. 2002, 66:1755-1758.
4. Shi W.B., Haberland M.E., Jien M.L., Shih D.M., Lusis A.J. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation. 2000, 102:75-81.
5. Duarte M.M., Rocha J.B., Moresco R.N., Duarted T., Cruza I.B., Loroa V.L., et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem. 2009, 42(7-8):666-671.
6. Hertog M.G., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., et al. Flavonoid intake and long-term risk of coronary heart- disease and cancer in the 7 countries study. Arch Intern Med. 1995, 155. 1184-1184.
7. Schmitt C.A., Dirsch V.M. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide-Biol Chem. 2009, 21:77-91.
8. Grassi D., Lippi C., Necozione S., Desideri G., Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr. 2005, 81:611-614.
9. Duffy S.J., Keaney J.F., Holbrook M., Gokce N., Swerdloff P.L., Frei B. Short-and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001, 04:151-156.
10. Frankel E.N., Waterhouse A.L., Teissedre P.L. Principal phenolic phytochemicals in selected Californian wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J. Agric.Food.Chem. 1995, 43:890-893.
11. Vinson J.A., Teufel K., Wu N. Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms. J. Agric.Food.Chem. 2004, 52:3661-3665.
12. Aviram M., Kassem E. Dietary olive oil reduces the susceptibility of low density lipoprotein to lipid peroxidation and inhibits lipoprotein uptake by macrophages. Ann. Nutr. Metab. 1993, 37:75-84.
13. Stangl V., Dreger H., Stangl K., Lorenz M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res. 2007, 73:348-358.
14. Giakoustidis A.E., Giakoustidis D.E., Iliadis S., Papageorgiou G., Koliakou K., Kontos N., et al. Attenuation of intestinal ischemia/reperfusion induced liver and lung injury by intraperitoneal administration of (and)-epigallocatechin-3-gallate. Free Radic. Res. 2006, 40:103-110.
15. Xu J.Z., Yeung S.Y., Chang Q., Huang Y., Chen Z.Y. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. Br J Nutr. 2004, 91:873-881.
16. Quist E.E. Regulation of erythrocyte membrane shape by Ca2+. Biochem Biophys. Res Commun. 1980, 92:631-637.
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72:248-254.
18. Ohkawa H., Ohishi N., Yagi K. Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979, 95:351-358.
19. Sinha A.K. Colorimetric assay of catalase. Anal Biochem. 1972, 47:389-394.
20. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974, 47:469-474.
21. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium. Biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
22. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979, 582:67-78.
23. Omaye S.T., Turnbull J.D., Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 1979, 62:3-11.
24. Desai I.D., Vitamin E. analysis methods for animal tissues. Methods Enzymol. 1984, 105:138-147.
25. King J. The dehydrogenases or oxidoreductase-lactate dehydrogenase. Practical clinical enzymology 1965, 83-93. Nostrand Company Ltd, London. D. Van (Ed.).
26. King J. The hydrolases-acid and alkaline phosphatases. Practical clinical enzymology 1965, 191-208. Nostrand Company Ltd, London. D. Van (Ed.).
27. King J. The transferases-alanine and aspartate transaminases. Practical clinical enzymology 1965, 121. Nostrand Company Ltd, London. D. Van (Ed.).
28. Drury R.A.D., Wallington E.A. Carleton's histological technique 1980, Oxford University Press, New York.
29. Hodis H.N., Crawford D.W., Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis. 1991, 89:117-126.
30. Brown M.S., Ho Y.K., Goldstein J.L. The cholesterol ester cycle in macrophage foam cells. J Biol Chem. 1980, 225:9344-9352.
31. Applebaum B.D., Haffner S.M., Hartsook E., Luk K.H., Albers J.J., Hazzard W.R. Down-regulation of the low-density lipoprotein receptor by dietary cholesterol. Am J Clin Nutr. 1984, 39:360-367.
32. Yu Y.M., Chang W.C., Wu C.H., Chiang S.Y. Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem. 2005, 16:675-681.
33. Lee M.K., Park Y.B., Moon S.S., Bokd S.H., Kime D.J., Ha T.Y., et al. Hypocholesterolemic and antioxidant properties of 3-(4-hydroxyl) propanoic acid derivatives in high-cholesterol fed rats. Chem Biol Interact. 2007, 170:9-19.
34. Gokkusu C., Ademoglu E., Turkoglu U.M., Oz H., Oz F. Thymosin alpha 1 protects liver and aorta from oxidative damage in atherosclerotic rabbits. Life Sci. 1996, 59:1059-1067.
35. Dayanandan A., Kumar P., Panneerselvam C. Protective role of L-carnitine on liver and heart lipid peroxidation in atherosclerotic rats. J Nutr Biochem. 2001, 12:254-257.
36. Thiruchenduran M., Vijayan N.A., Sawaminathan J.K., Devaraj S.N. Protective effect of grape seed proanthocyanidins against cholesterol cholic acid diet-induced hypercholesterolemia in rats. Cardiovasc Pathol. 2011, 20:361-368.
37. Agar N.S., Sadrzadeh S.M., Hallaway P.E., Eaton J.W. Erythrocyte catalase. A somatic oxidant defense?. J Clin. 1986, 77:319-321.
38. Sudhahar V., Ashok Kumar S., Varalakshmi P. Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia. Life Sci. 2006, 78:1329-1335.
39. Hatano T., Edamatsu R., Hiramatsu M., Mori A., Fujita Y., Yasuhara T., et al. Effects of the interaction of tannins with co-existing substances. VI. Effects of tannins and related polyphenols on superoxide anion radical and on 1,1-diphenyl-2-picrylhydrazyl radical. Chem Pharm Bull. 1989, 37:2016-2021.
40. Wang W.F., Luo J., Yao S.D., Lian Z.R., Zhang J.S., Lin N.Y. Interaction of phenolic antioxidants and hydroxyl radicals. Radiat Phys Chem. 1993, 42:985-987.
41. Pannala A.S., Rice-Evans C.A., Halliwell B., Singh S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem Biophys Res Commun. 1997, 232:164-168.
42. Freeman B.A., Crapo J.D. Biology of disease: free radicals and tissue injury. Lab Invest. 1982, 47:412-426.
43. Sudhahar V., Kumar S.A., Sudharsan P.T., Varalakshmi P. Protective effect of lupeoland its ester on cardiac abnormalities in experimental hypercholesterolemia. Vascul Pharmacol. 2007, 46:412-418.
44. Mitani H., Egashira K., Kimura M. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits. Pharmacol Res. 2003, 48:417-427.
45. Sohn E.J., Kang D.G., Mun Y.J., Woo W.H., Lee H.S. Antiatherogenic effects of the methanol extract of sorbus cortex in atherogenic-diet rats. Biol Pharm Bull. 2005, 28:1444-1449.